GCS
PFE icon

Gordian Capital (Singapore)’s Pfizer PFE Stock Holding History

Gordian Capital (Singapore)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,000
Closed -$99.6K – 162
2025
Q4 		$99.6K Buy
+4,000
New +$101K 0.14% 77
2024
Q4 		– Sell
-10
Closed -$289 – 201
2024
Q3 		$289 Hold
10
– – ﹤0.01% 151
2024
Q2 		$280 Hold
10
– – ﹤0.01% 139
2024
Q1 		$278 Buy
+10
New +$277 ﹤0.01% 89
2022
Q2 		– Sell
-4,000
Closed -$211K – 145
2022
Q1 		$211K Hold
4,000
– – 0.17% 49
2021
Q4 		$237K Buy
+4,000
New +$198K 0.19% 48

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Gordian Capital (Singapore)'s PFE Position: Q1 2026 in Review

Gordian Capital (Singapore) sold out of Pfizer (PFE) in Q1 2026, closing a stake of 4,000 shares — an estimated $99.6K sold.

Gordian Capital (Singapore) first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $237K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Gordian Capital (Singapore) reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 4,000 Pfizer shares in Q1 2026, an estimated $99.6K.
  • Gordian Capital (Singapore) first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
  • Gordian Capital (Singapore)'s Pfizer position peaked at $237K in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2026, filed 13 May 2026.